Cargando…
mFast‐SeqS‐based aneuploidy score in circulating cell‐free DNA is a prognostic biomarker in prostate cancer
Multiple prognostic biomarkers, including circulating tumour cell (CTC) counts, exist in metastatic castration‐resistant prostate cancer (mCRPC) patients, but none of them have been implemented into daily clinical care. The modified fast aneuploidy screening test‐sequencing system (mFast‐SeqS), whic...
Autores principales: | Isebia, Khrystany T., Mostert, Bianca, Deger, Teoman, Kraan, Jaco, de Weerd, Vanja, Oomen‐de Hoop, Esther, Hamberg, Paul, Haberkorn, Brigitte C. M., Helgason, Helgi H., de Wit, Ronald, Mathijssen, Ron H. J., Lolkema, Martijn P., Wilting, Saskia M., van Riet, Job, Martens, John W. M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10483599/ https://www.ncbi.nlm.nih.gov/pubmed/37178439 http://dx.doi.org/10.1002/1878-0261.13449 |
Ejemplares similares
-
Genome‐wide aneuploidy detected by mFast‐SeqS in circulating cell‐free DNA is associated with poor response to pembrolizumab in patients with advanced urothelial cancer
por: Mendelaar, Pauline A. J., et al.
Publicado: (2022) -
A Compendium of AR Splice Variants in Metastatic Castration-Resistant Prostate Cancer
por: Isebia, Khrystany T., et al.
Publicado: (2023) -
Tumor-agnostic ctDNA levels by mFAST-SeqS in first-line HR-positive, HER2 negative metastatic breast cancer patients as a biomarker for survival
por: Verschoor, Noortje, et al.
Publicado: (2023) -
Measuring antigen expression of cancer cell lines and circulating tumour cells
por: Mentink, Anouk, et al.
Publicado: (2023) -
Characterizing Circulating Tumor Cells and Tumor-Derived Extracellular Vesicles in Metastatic Castration-Naive and Castration-Resistant Prostate Cancer Patients
por: Isebia, Khrystany T., et al.
Publicado: (2022)